QuarterHawk — Equity ResearchQuarterHawk — Equity Research

FMC Corporation (FMC)

Basic Materials

No action
Fundamental
1
Sentiment
2
Technical
2

Do Nothing: fundamentalScore 1 and qualitativeScore 2 both sit below the required floor of 3, so no bullish entry is permitted regardless of the chart; independently, no pullback limit qualifies (price 5.745 < SMA50 8.64 with MACD line -0.72 < 0 = countertrend, and price under a declining SMA200 without a reclaim) and no breakout stop offers an R/R-viable settled level.

Analysis as of 2026-11-06· more than 2 trading days ago

Company overview

FMC Corporation is an agricultural science company providing crop protection chemicals, plant health products, and pest management solutions. It operates globally, distributing through sales teams, partners, and independent distributors.

Fundamental

very weak
Fundamental1
Severely distressed

FMC's financials show significant distress with negative equity, cash flow, and high leverage.

Severely distressed. Total stockholders' equity has fallen to a $(19.4) million deficit, adjusted EBITDA was negative $(333.9) million for nine months of 2026, operating cash flow was negative $(231.3) million, and $4.18 billion of debt sits against a market capitalisation near $719 million. Ratings are below investment grade and the revolver has already been amended three times for covenant relief, with $1.2 billion of new 8.000% secured debt issued in June 2026. Revenue is contracting under generic competition on the core diamide franchise; economic value currently belongs to the lenders rather than the equity.

Sentiment

weak
Sentiment2
Weak post-event absorption

Sentiment is deteriorating post-earnings with no positive catalysts in the near term.

A weak, post-event absorption setup. The dominant catalyst is the 2026-10-29 Q3 print and revised Q4/outlook — revenue $105.9M versus $542M, a $2.07B net loss and negative FY26 EBITDA — an announced, bearish earnings catalyst still being digested, with post-print sell-side target cuts (Argus to $4.00, below the $5.745 quote) layered on top and no forward-dated bullish or neutral event inside 30 days. The sentiment delta is determinate and deteriorating (near-flat baseline polarity_score ≈ -0.02 → bearish scoring ≈ -0.32, 15 scored items in each window), retail is unmeasured, and a moderate red-flag cap applied for sharply deteriorating sentiment with no offsetting market-rewarded bullish catalyst; the severe screen — regulator-confirmed fraud/accounting action, going concern, auditor change, refinancing wall inside 30 days — is clear.

Technical

weak
Technical2
Weak-bearish trend

FMC is in a strong downtrend with no confirmed bullish setup.

Chart read: FMC is locked in a primary downtrend. Price 5.745 sits below SMA20 5.87, SMA50 8.64, SMA200 12.22, EMA9 5.86, EMA21 6.32, WMA9 5.93 and the daily VWAP 5.77, so the moving-average stack is fully bearish-aligned. ADX14 at 39.48 confirms a strong directional trend, and with price beneath every average that strength points down, not up. The only constructive elements are mechanical repair off a capitulation low: RSI14 40.21 recovering from 14-16 prints on 2026-10-26/28, and MACD histogram +0.26 (line -0.72 above signal -0.98) positive since 2026-10-30. The 2026-10-29/11-02 short-covering squeeze from 4.37 to 6.64 has already rolled over into lower highs (6.64 -> 6.61 -> 5.90) and today's -6.1% close at 5.745, back under the 10/30 gap zone. Bounce-only, no trend confirmation -> technicalScore 2. The trade is barred upstream regardless: fundamentalScore 1 and qualitativeScore 2 are both below the required floor of 3.

You’re looking at 2026-11-06 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.